Kfar Saba, Israel (December 4, 2012) – NLT SPINE, a developer of products for Minimally Invasive Spine Surgery (MISS) and percutaneous procedures, announced today that Peter Wehrly has joined the company’s Board of Directors. Didier Toubia, NLT SPINE’s CEO, welcomed Mr. Wehrly, saying, “As we prepare the platform’s introduction in the market, we are happy to have Peter Wehrly on our Board of Directors. As a seasoned executive Peter can contribute from his vast knowledge, experience and network to advance our commercialization strategy. I am positive that his contribution will be invaluable to NLT SPINE.” He added.
Mr. Wehrly brings over 25 years of experience and expertise in the medical device field, and formerly served as President of Medtronic’s $3 billion Spinal, Biologics and Navigation Division.
He is the Group President of Covidien plc, a position he has held since July 2011. In this position, he is responsible for the Respiratory & Monitoring Solutions and Vascular Therapy businesses, as well as the Japan, Australia-New Zealand and Canada businesses.
Mr. Wehrly held several executive-level roles at Medingo and Medtronic. He is a graduate of Ball State University (Indiana) with a Bachelor of Science degree in Management.
“Joining as a board member at NLT SPINE will enable me to work closely with a team of experts in their fields to advance the company’s impressive technology platform, which addresses important surgical problems.” Peter Wehrly commented. “The ingenuity and industrious nature of the development team, characteristic of Israeli Life Science start-up companies, played a major part in my decision to take part in bringing this technology to the market.”
For more information about the company and technology please visit http://www.nlt-spine.com
About NLT SPINE
NLT SPINE specializes in the development of innovative Minimally Invasive Spinal Surgery (MISS) and percutaneous procedures for treating degenerative spinal conditions. The company’s vision is to improve patient care and reduce total treatment costs by shifting from traditional open surgical routines to MISS, employing new methods and technologies to enhance usability and outcomes.
Led by top international leaders in spinal surgery, NLT SPINE holds a wide portfolio of pending and issued patents that cover the non-linear core technology and related implant and instrument technologies.
Media contact:
Tom Keegan
Vice President Business Development and US Marketing
tom.k@nlt-spine.com
Tel: 508-272-7750
